Matrixyl vs Melanotan II

Matrixyl: Palmitoyl pentapeptide that signals fibroblasts to rebuild collagen and elastin. Typical dose 3-5% topical concentration mcg. Melanotan II: Synthetic melanocortin peptide with tanning, appetite-suppressive, and sexual function effects. Typical dose 250-1000 mcg. Both fall under the Cosmetic category.

Stacking Matrixyl with Melanotan II is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.

Matrixyl is typically dosed: Once or twice daily for Topical anti-aging (cosmetic). Melanotan II is typically dosed: Once daily for Tanning (loading phase); Once or twice weekly for Tanning (maintenance); As needed, 1-2 hours before activity for Sexual function enhancement.

Matrixyl: Cosmetic ingredient (not regulated as a drug). Melanotan II: Not FDA approved. The FDA has issued warnings against the use of Melanotan II, citing it as an unregulated and potentially dangerous product. The derivative PT-141 (bremelanotide/Vyleesi) was approved for sexual dysfunction but Melanotan II itself was not pursued for approval.